Mabwell has received approval from NMPA to begin Phase II trials for its innovative anti-IL-11 monoclonal antibody, 9MW3811, targeting pathological scarring.

Elanco has successfully completed a major expansion of its Kansas manufacturing facility, enhancing its production of innovative monoclonal antibody treatments for pets.

Insmed Incorporated reveals key outcomes from its clinical trials for brensocatib, alongside an exciting new acquisition that promises to enhance its therapeutic offerings.

Zentiva makes a significant entry into the biosimilars sector, introducing its first monoclonal antibody to enhance access to quality biological treatments across Europe.

Zentiva has officially entered the biosimilar market with the launch of its first monoclonal antibody across the EU, enhancing access to high-quality biologics.

Zentiva, a prominent European producer of affordable medicines, has initiated the launch of its first biosimilar, enhancing access to essential treatments across Europe.

Zentiva marks its entry into the biosimilars market with the launch of its first monoclonal antibody in the EU, reinforcing healthcare access.

Enquyst Technologies has introduced pioneering chromatography-free technology for monoclonal antibody processing, boosting yields and purity. They were awarded $10.5M in funding to scale their IPP platform.

Bio-Techne announces a strategic alliance with USP to improve the development of monoclonal antibodies and gene therapy products, ensuring higher quality standards.